TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
POA Pharma Scandinavia AB
Closing information (x1000 NOK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
107,967
|
93,428
|
81,313 |
| Financial expenses |
978
|
180
|
22 |
| Earnings before taxes |
-778
|
1,451
|
3,777 |
| EBITDA |
679
|
2,429
|
4,668 |
| Total assets |
57,911
|
51,767
|
39,115 |
| Current assets |
56,349
|
49,510
|
36,692 |
| Current liabilities |
30,683
|
25,184
|
13,606 |
| Equity capital |
27,228
|
26,583
|
25,509 |
| - share capital |
104
|
98
|
96 |
| Employees (average) |
13
|
13
|
12 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
47.0%
|
51.4%
|
65.2% |
| Turnover per employee |
8,305
|
7,187
|
6,776 |
| Profit as a percentage of turnover |
-0.7%
|
1.6%
|
4.6% |
| Return on assets (ROA) |
0.3%
|
3.2%
|
9.7% |
| Current ratio |
183.6%
|
196.6%
|
269.7% |
| Return on equity (ROE) |
-2.9%
|
5.5%
|
14.8% |
| Change turnover |
8,743
|
10,292
|
5,864 |
| Change turnover % |
9%
|
12%
|
8% |
| Chg. No. of employees |
0
|
1
|
-2 |
| Chg. No. of employees % |
0%
|
8%
|
-14% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.